{
  "ptid_time": "126_S_4507_2012-02-03",
  "img_path": "/data/qiuhui/data/adni/images/126_S_4507/2012-02-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 57,935 mm³, 50.4% above the reference mean. With a Z-score of 1.21 (88.6th percentile), this represents mild enlargement; hippocampal volume measures 6,491 mm³, 14.1% below the reference mean. With a Z-score of -1.38 (8.4th percentile), this represents mild atrophy; whole brain volume measures 1,131,870 mm³, 4.9% above the reference mean. With a Z-score of 0.63 (73.6th percentile), this represents normal volume . ",
  "text_data": "Age is 78.2 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 29.0. MoCA: 22.0. Logical Memory: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.63 SUVR (profound elevated); Amyloid beta: 697.30 pg/mL (normal ); Total tau: 281.80 pg/mL (normal ); Phosphorylated tau: 30.48 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild hippocampal atrophy (Z-score -1.38) and mild ventricular enlargement, which are structural changes often seen in early neurodegeneration. Despite normal Aβ and T-tau levels, the profound AV45 (amyloid PET) elevation and mildly elevated P-tau suggest underlying Alzheimer’s pathology, while cognitive testing (MoCA 22) indicates mild impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **Medium** (due to conflicting biomarkers—normal CSF Aβ but elevated AV45—though clinical and structural findings align with MCI)",
  "timestamp": "2025-07-26T12:46:35.531736"
}